A House Energy and Commerce Committee hearing on clean energy technologies shows division among the parties, with one main agreement: the U.S. will lose out on this market if Washington allows for dependence on Asia for solar, wind and EV battery materials.
An eye-opening exclusive by the WSJ shows just how much time and energy is being spent by American companies and Silicon Valley venture capitalists investing in semiconductor production…in China. The U.S. needs the CHIPS Act passed this year.
In a House Financial Services Committee hearing on Thursday, Congress appears frustrated in stopping illicit supply chains, and worries about China’s growing resource dominance in high tech and clean tech supply chains.
The Senate Judiciary Committee hears from witnesses on how to combat online-sold counterfeit goods from flooding the U.S. They missed one key remedy — de minimis rulemaking needs a closer look.
An Indian drug market that’s been the subject of FDA warnings since 2017 is the apparent source of tainted medication sold in the U.S. and Canada. This is another example as to why we need to reshore critical supply of essential medication. Where is Congress?
By Charles Benoit, CPA Trade Counsel Regrettably, the Biden Administration announced last week that they’re open to tariff cuts to imports of Made-in-China merchandise. First
Whether China’s energy crunch is Beijing climate policy shooting some provinces in the foot or not, blackouts and factory closures will pressure U.S. supply chains that remain overly reliant on China. It’s time to move out of there.
A Deloitte survey of CFOs says that nearly half are facing serious supply chain disruptions. They all want to move away from a China-centric model. But will their new “supply chain resilience” push mean nothing for U.S. manufacturing, everything from Southeas Asia and Mexico?